Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/27/19
End: 07/17/19
Due: 07/17/20
Phase: N/A
Priority: Normal
Start: 10/05/20
End: 12/17/21
Due: 12/17/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR) | NCT04232644 | Vallon Pharmaceuticals, Inc. | user2@example.com | None | 2019-05-27 | 2019-07-17 | 2020-07-17 | - | - | 2025-07-14 |
| Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR) | NCT04647903 | Vallon Pharmaceuticals, Inc. | user2@example.com | None | 2020-10-05 | 2021-12-17 | 2022-12-17 | - | - | 2025-07-14 |